Asia Genomics

NantHealth, Asia Genomics expand GPS Cancer in Southeast Asia

Tuesday, September 5, 2017

NantHealth, a next-generation, evidence-based, personalized healthcare company, announced that it has entered into an agreement for GPS Cancer, a proteogenomic molecular test that helps guide treatment strategies including choice of standard chemotherapy for oncologists, with Asia Genomics, a provider and distributor of molecular testing services and key player in the field of personalized medicine in Southeast Asia.

[Read More]